RxDoctor Payments Data

Getahun Abate, MD

Infectious Disease · Saint Louis, MONPI 1881885044

Payments from drug & device makers

What this record shows

That places this record below the midpoint for infectious disease clinicians in MO, where the typical reported total is $219.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$350,844in research payments, 2019–2025

Across 49 payments — averaging $7160.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bavarian Nordic A/s$350K
  • Gilead$1K

How this compares

$0 in reported general payments places this provider in the 10th percentile of 177 infectious disease providers in Missouri.

See all infectious disease providers in Missouri

Medicare billing

Part B allowed, 2024
$13,148
Medicare patients
65
Services billed
111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →